Across all subtypes, high expression of Ki67, MCM2, Cyclin A, and PHH3 was significantly associated with reduced OS in multivariable models.<h4>Conclusions</h4>Subtype‐specific immune infiltration and elevated proliferation activity are key predictors of disease trajectory in advanced breast cancer. Here, MCM2 is linked to breast carcinoma.